Stimera Appoints Lon Kreger as CEO to Lead Commercial Growth

Stimera, formerly BioAge, transitions leadership to drive expansion of its molecular foliar fertilizer technology.

Mar. 16, 2026 at 5:01pm by Ben Kaplan

Stimera, a crop science company developing patent-pending molecular foliar fertilizers, has appointed Lon E. Kreger as its new Chief Executive Officer. Kreger's appointment marks an important step in Stimera's evolution as it transitions from product validation to broader commercial scale. Stimera's flagship product, Nitro-Gro, is engineered to alter the molecular structure of nutrient inputs to improve plant absorption and metabolism.

Why it matters

Stimera's technology aims to help growers achieve more predictable yields, better crop timing, and stronger returns on their fertility investments. As the company moves from regional development to global commercialization, Kreger's leadership will be crucial in leveraging trusted agricultural channels to bring Stimera's solutions directly to market.

The details

Stimera, formerly known as BioAge, has appointed Lon E. Kreger as its new Chief Executive Officer. Kreger's appointment comes as the company transitions from product validation and early market traction toward broader commercial scale. Stimera is developing patent-pending molecular foliar fertilizers designed to make nutrients behave like biostimulants, with its flagship product Nitro-Gro engineered to alter the molecular structure of nutrient inputs to improve plant absorption and metabolism.

  • Stimera announced Kreger's appointment on March 16, 2026.

The players

Stimera

A crop science company developing patent-pending molecular foliar fertilizers, formerly known as BioAge.

Lon E. Kreger

The newly appointed Chief Executive Officer of Stimera, tasked with leading the company's commercial growth and expansion.

Reuben R. Rampersad

The Founder and President of Stimera, who holds a Ph.D. in plant physiology and will continue to lead product development, formulation strategy, and pipeline expansion.

Got photos? Submit your photos here. ›

What they’re saying

“At Stimera, we are focused on delivering products that drive measurable results. Growers need solutions that are effective, reliable, and economically sound. By helping growers maximize yield and efficiency, we strengthen the entire supply chain and support the production of high-quality food.”

— Lon Kreger, Chief Executive Officer

“Stimera technology was built to solve real problems – helping growers achieve more predictable yields, better crop timing, and stronger returns from their fertility spend. Stimera has the kind of foundation that investors and commercial partners look for in a differentiated product with superior, early-season performance, and a model that can scale through established channels.”

— Lon Kreger, Chief Executive Officer

“Using scientific rigor, Reuben created a new category of crop inputs – molecular fertilizers – to develop the next generation of plant nutrition. Reuben is a visionary scientist who realized an impactful change was needed. My role is to put this technology into the hands of the grower – who it was designed to benefit.”

— Lon Kreger, Chief Executive Officer

“Stimera was built on the belief that crop nutrition can do more than correct deficiencies – it can actively improve how the plant performs. We have worked hard to develop products that help nutrients move faster, work harder, and deliver meaningful economic value to growers. Bringing Lon in as CEO gives us the commercial and operational leadership to scale that vision.”

— Reuben R. Rampersad, Founder and President

What’s next

Stimera will showcase its molecular fertilizer technology at the World Agri-Tech Innovation Summit in San Francisco, California, on March 17–18, 2026.

The takeaway

Stimera's appointment of Lon Kreger as CEO signals the company's transition from product validation to broader commercial scale, as it looks to leverage its innovative molecular fertilizer technology to help growers achieve higher yields, better crop timing, and stronger returns on their fertility investments.